• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧反应模式的特征鉴定了膀胱癌的预后和免疫治疗反应。

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer.

作者信息

Cao Rui, Ma Bo, Wang Gang, Xiong Yaoyi, Tian Ye, Yuan Lushun

机构信息

Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Department of Stomatology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

出版信息

Mol Ther Oncolytics. 2021 Jul 2;22:277-293. doi: 10.1016/j.omto.2021.06.011. eCollection 2021 Sep 24.

DOI:10.1016/j.omto.2021.06.011
PMID:34553019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8426180/
Abstract

Intra-tumoral hypoxia and immunity are highly correlated with prognosis of tumor patients. Nonetheless, no studies have reported a systematic analysis of the relationship between hypoxia response and immunity in bladder cancer (BLCA). In this study, we comprehensively evaluated the hypoxia response patterns and their association with genomic and clinicopathological characteristics of 1,343 BLCA patients using unsupervised consensus clustering. Five hypoxia response patterns were defined, and the HPXscore was constructed using least absolute shrinkage and selection operator (LASSO)-Cox regression algorithms to represent the individual hypoxia response pattern. The low HPXscore group was characterized by immune activation and high DNA damage repair, which was referred to the immune-inflamed phenotype. However, activation of stromal-related pathways was observed in the high HPXscore group, which is recognized as T cell suppressive and more likely to be an immune-excluded phenotype. Furthermore, the HPXscore was an independent prognostic factor and could act as a good predictor for immunotherapeutic outcomes in BLCA. Thus, depicting a comprehensive landscape of the hypoxia characteristics may therefore help us to interpret the underlying mechanism of immune escape and shed light on the clinical application of hypoxia modification and immune checkpoints targeting immunotherapies for BLCA.

摘要

肿瘤内缺氧与免疫状态与肿瘤患者的预后高度相关。然而,尚无研究报道对膀胱癌(BLCA)中缺氧反应与免疫之间的关系进行系统分析。在本研究中,我们采用无监督一致性聚类方法,全面评估了1343例BLCA患者的缺氧反应模式及其与基因组和临床病理特征的关联。定义了五种缺氧反应模式,并使用最小绝对收缩和选择算子(LASSO)-Cox回归算法构建了HPXscore,以代表个体的缺氧反应模式。低HPXscore组的特征是免疫激活和高DNA损伤修复能力,这被称为免疫炎症表型。然而,在高HPXscore组中观察到基质相关通路的激活,这被认为具有T细胞抑制作用,更可能是一种免疫排除表型。此外,HPXscore是一个独立的预后因素,并且可以作为BLCA免疫治疗结果的良好预测指标。因此,描绘缺氧特征的全面图景可能有助于我们解释免疫逃逸的潜在机制,并为针对BLCA的缺氧修饰和免疫检查点靶向免疫治疗的临床应用提供启示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/0d0770a49fc9/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/5ac6ed335b2a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/0d8b0bb0fc88/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/1b07df2d7631/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/841ed850110e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/854086189ca1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/3f38575d546a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/cf1d11e59bcc/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/8577572768d8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/0d0770a49fc9/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/5ac6ed335b2a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/0d8b0bb0fc88/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/1b07df2d7631/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/841ed850110e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/854086189ca1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/3f38575d546a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/cf1d11e59bcc/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/8577572768d8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fb/8426180/0d0770a49fc9/gr8.jpg

相似文献

1
Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer.缺氧反应模式的特征鉴定了膀胱癌的预后和免疫治疗反应。
Mol Ther Oncolytics. 2021 Jul 2;22:277-293. doi: 10.1016/j.omto.2021.06.011. eCollection 2021 Sep 24.
2
New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer.膀胱癌新的预后基因特征及免疫逃逸机制
Front Cell Dev Biol. 2022 May 12;10:775417. doi: 10.3389/fcell.2022.775417. eCollection 2022.
3
Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer.膀胱癌治疗与预后中铁代谢图谱的识别与定量分析
Front Cell Dev Biol. 2022 Feb 21;10:810272. doi: 10.3389/fcell.2022.810272. eCollection 2022.
4
CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer.CD93 调控肿瘤微环境,并预测膀胱癌的分子亚型和治疗反应。
Comput Biol Med. 2022 Aug;147:105727. doi: 10.1016/j.compbiomed.2022.105727. Epub 2022 Jun 29.
5
Hypoxia is correlated with the tumor immune microenvironment: Potential application of immunotherapy in bladder cancer.缺氧与肿瘤免疫微环境相关:免疫疗法在膀胱癌中的潜在应用。
Cancer Med. 2023 Dec;12(24):22333-22353. doi: 10.1002/cam4.6617. Epub 2023 Dec 8.
6
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.Siglec15 塑造非炎症性肿瘤微环境,并预测膀胱癌的分子亚型。
Theranostics. 2021 Jan 1;11(7):3089-3108. doi: 10.7150/thno.53649. eCollection 2021.
7
Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA).鉴定自噬相关基因特征可预测膀胱癌 (BLCA) 的化疗和免疫治疗效果。
J Cell Mol Med. 2021 Jun;25(12):5417-5433. doi: 10.1111/jcmm.16552. Epub 2021 May 7.
8
Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.肿瘤表达谱分析建立并验证了一种基于膀胱癌免疫相关基因的预后模型。
Front Genet. 2021 Aug 27;12:696912. doi: 10.3389/fgene.2021.696912. eCollection 2021.
9
Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.基于TCGA的生物信息学分析对膀胱癌新型预后转录因子和免疫相关基因特征的临床前分析
Oncol Lett. 2021 May;21(5):344. doi: 10.3892/ol.2021.12605. Epub 2021 Mar 3.
10
Exploration of Different Hypoxia Patterns and Construction of a Hypoxia-Related Gene Prognostic Index in Colorectal Cancer.探讨结直肠癌不同缺氧模式并构建与缺氧相关的基因预后指标。
Front Immunol. 2022 May 30;13:853352. doi: 10.3389/fimmu.2022.853352. eCollection 2022.

引用本文的文献

1
Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach.采用层层自组装方法构建靶向 EGFR+膀胱癌细胞的弹性蛋白样多肽核酸递送系统。
Biomacromolecules. 2024 Sep 9;25(9):5729-5744. doi: 10.1021/acs.biomac.4c00165. Epub 2024 Aug 26.
2
Integration of Single-Cell and Bulk RNA-seq Data to Identify the Cancer-Associated Fibroblast Subtypes and Risk Model in Glioma.整合单细胞和批量RNA测序数据以鉴定神经胶质瘤中癌症相关成纤维细胞亚型和风险模型
Biochem Genet. 2025 Apr;63(2):1275-1297. doi: 10.1007/s10528-024-10751-3. Epub 2024 Mar 27.
3

本文引用的文献

1
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.膀胱癌的基因组异质性:提高治疗效果的挑战和可能的解决方案。
Nat Rev Urol. 2020 May;17(5):259-270. doi: 10.1038/s41585-020-0304-1. Epub 2020 Mar 31.
2
Role of hypoxia in cancer therapy by regulating the tumor microenvironment.缺氧在肿瘤微环境调控中的癌症治疗作用。
Mol Cancer. 2019 Nov 11;18(1):157. doi: 10.1186/s12943-019-1089-9.
3
An EMT-related gene signature for the prognosis of human bladder cancer.一个 EMT 相关基因标志物用于预测人类膀胱癌的预后。
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment.
胰腺癌中的高缺氧状态与免疫抑制性肿瘤微环境的多个特征有关。
Front Immunol. 2024 Mar 6;15:1360629. doi: 10.3389/fimmu.2024.1360629. eCollection 2024.
4
Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma.m6A 修饰与肺腺癌肿瘤微环境浸润特征的关联。
Exp Biol Med (Maywood). 2023 Dec;248(23):2273-2288. doi: 10.1177/15353702231214266. Epub 2024 Jan 2.
5
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.缺氧诱导的 PLOD2 通过调节 EGFR 依赖性 AKT 通路激活促进肾透明细胞癌进展。
Cell Death Dis. 2023 Nov 27;14(11):774. doi: 10.1038/s41419-023-06298-7.
6
Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer.整合多组学分析和机器学习优化肌肉浸润性尿路上皮癌的分子亚型及预后。
Mol Ther Nucleic Acids. 2023 Jun 5;33:110-126. doi: 10.1016/j.omtn.2023.06.001. eCollection 2023 Sep 12.
7
An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.N6-甲基腺苷调控和 mRNAsi 相关预后指数揭示了低级别脑胶质瘤中独特的免疫微环境和免疫治疗反应。
BMC Bioinformatics. 2023 Jun 1;24(1):225. doi: 10.1186/s12859-023-05328-7.
8
Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer.膀胱癌 mRNA 疫苗开发中肿瘤抗原的挖掘和免疫亚型分类器的构建。
Front Immunol. 2022 Nov 16;13:1014638. doi: 10.3389/fimmu.2022.1014638. eCollection 2022.
9
Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer.基于液-液相分离及其与膀胱癌免疫表型相互作用的分子亚型鉴定。
Front Immunol. 2022 Nov 28;13:1059568. doi: 10.3389/fimmu.2022.1059568. eCollection 2022.
10
Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma.T细胞增殖的正调节因子作为预测肺腺癌预后和描绘免疫格局的生物标志物。
Front Genet. 2022 Nov 25;13:1003754. doi: 10.3389/fgene.2022.1003754. eCollection 2022.
J Cell Mol Med. 2020 Jan;24(1):605-617. doi: 10.1111/jcmm.14767. Epub 2019 Oct 28.
4
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges.基于靶向基因panel 的肿瘤突变负荷定量:主要进展与挑战
J Immunother Cancer. 2019 Jul 15;7(1):183. doi: 10.1186/s40425-019-0647-4.
5
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.一种携带 p53 基因的肿瘤靶向纳米医学药物能够穿透血脑屏障,并增强胶质母细胞瘤小鼠模型的抗 PD-1 免疫治疗效果。
Int J Cancer. 2019 Nov 1;145(9):2535-2546. doi: 10.1002/ijc.32531. Epub 2019 Jul 8.
6
Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours.新型 TCR 基生物制剂:动员 T 细胞为“冷”肿瘤加温。
Cancer Treat Rev. 2019 Jul;77:35-43. doi: 10.1016/j.ctrv.2019.06.001. Epub 2019 Jun 12.
7
Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity.缺氧诱导的表型介导肿瘤异质性。
Adv Exp Med Biol. 2019;1136:43-55. doi: 10.1007/978-3-030-12734-3_3.
8
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy.细胞周期及其他:利用RB1调控的新机制进行癌症治疗
Trends Cancer. 2019 May;5(5):308-324. doi: 10.1016/j.trecan.2019.03.005. Epub 2019 Apr 30.
9
Urinary biomarkers in bladder cancer: where do we stand?膀胱癌的尿生物标志物:我们处于什么位置?
Curr Opin Urol. 2019 May;29(3):203-209. doi: 10.1097/MOU.0000000000000605.
10
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.